The GSEA analysis comparing tumors from control and DIO mice revealed that DIO modulated numerous cancer-associated pathways, including hypoxia, KRAS signaling, and the epithelial-to-mesenchymal transition (EMT), as well as one immune-related gene set. Here, KRAS is linked to cancer.